Xenical Study Supports Proposed Nonprescription Dose, Glaxo Says
This article was originally published in The Tan Sheet
Executive Summary
The "behavior modification" effect ofXenical adverse events could help allay concerns that OTC availability would lead to people using orlistat without making appropriate adjustments to their diets, according to the principal investigator of a study on the drug